do-me/EUR-LEX huggingface dataset:
Case T-159/25: Action brought on 7 March 2025 – Adamed Pharma v Parliament and Council
Date: 2025-03-07
Institutions: General Court
Subjects: equal treatment, extended producer responsibility, freedom of association, pharmaceutical industry, polluter pays principle, principle of legal certainty, principle of proportionality, producer's liability, wastewater, water treatment








C_202502675EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2025/2675


19.5.2025






Action brought on 7 March 2025 – Adamed Pharma v Parliament and Council


(Case T-159/25)

(C/2025/2675)
Language of the case: English

Parties


Applicant: Adamed Pharma S.A. (Pieńków, Poland) (represented by: T. Voland, U. Reese, M. Petite, P. Leven, L.-I. Dietz, M. Steininger and K. Schroeder-Finckh, lawyers)

Defendants: European Parliament, Council of the European Union

Form of order sought

The applicant claims that the Court should:






—


declare null and void Article 1, Article 2(19), (20) and (26), Article 9, Article 10, Article 30(1) sub-paragraph 2(c) and (g) and Annex III of the Directive (EU) 2024/3019 of the European Parliament and of the Council of 27 November 2024 concerning urban wastewater treatment (‘UWWTD’) (1);










—


in the alternative declare these provisions null and void to the extent that they concern the applicant;










—


in the alternative declare null and void the entire UWWTD; and,










—


order the defendants to pay the costs of the proceedings.





Pleas in law and main arguments

In support of the action, the applicant relies on the same pleas in law as in Case T-156/25, Accord Healthcare France v Parliament and Council.


(1)  OJ 2024 L 3019.


ELI: http://data.europa.eu/eli/C/2025/2675/oj
ISSN 1977-091X (electronic edition)
Case T-161/25: Action brought on 7 March 2025 – hameln pharma v Parliament and Council
Date: 2025-03-07
Institutions: General Court
Subjects: equal treatment, extended producer responsibility, freedom of association, pharmaceutical industry, polluter pays principle, principle of legal certainty, principle of proportionality, producer's liability, wastewater, water treatment








C_202502677EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2025/2677


19.5.2025






Action brought on 7 March 2025 – hameln pharma v Parliament and Council


(Case T-161/25)

(C/2025/2677)
Language of the case: English

Parties


Applicant: hameln pharma GmbH (Hameln, Germany) (represented by: T. Voland, U. Reese, M. Petite, P. Leven, L.-I. Dietz, M. Steininger and K. Schroeder-Finckh, lawyers)

Defendants: European Parliament, Council of the European Union

Form of order sought

The applicant claims that the Court should:






—


declare null and void Article 1, Article 2(19), (20) and (26), Article 9, Article 10, Article 30(1) sub-paragraph 2(c) and (g) and Annex III of the Directive (EU) 2024/3019 of the European Parliament and of the Council of 27 November 2024 concerning urban wastewater treatment (‘UWWTD’) (1);










—


in the alternative declare these provisions null and void to the extent that they concern the applicant;










—


in the alternative declare null and void the entire UWWTD; and,










—


order the defendants to pay the costs of the proceedings.





Pleas in law and main arguments

In support of the action, the applicant relies on the same pleas in law as in Case T-156/25, Accord Healthcare France v Parliament and Council.


(1)  OJ 2024 L 3019.


ELI: http://data.europa.eu/eli/C/2025/2677/oj
ISSN 1977-091X (electronic edition)
Case T-167/25: Action brought on 7 March 2025 – Teva Nederland and Others v Parliament and Council
Date: 2025-03-07
Institutions: General Court
Subjects: equal treatment, extended producer responsibility, freedom of association, pharmaceutical industry, polluter pays principle, principle of legal certainty, principle of proportionality, producer's liability, wastewater, water treatment








C_202502683EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2025/2683


19.5.2025






Action brought on 7 March 2025 – Teva Nederland and Others v Parliament and Council


(Case T-167/25)

(C/2025/2683)
Language of the case: English

Parties


Applicants: Teva Nederland BV (Haarlem, Netherlands) and five others (represented by: T. Voland, U. Reese, M. Petite, P. Leven, L.-I. Dietz, M. Steininger and K. Schroeder-Finckh, lawyers)

Defendants: European Parliament, Council of the European Union

Form of order sought

The applicants claim that the Court should:






—


declare null and void Article 1, Article (19), (20) and (26), Article 9, Article 10, Article 30(1) sub-paragraph 2(c) and (g) and Annex III of the Directive (EU) 2024/3019 of the European Parliament and of the Council of 27 November 2024 concerning urban wastewater treatment (‘UWWTD’) (1);










—


in the alternative declare these provisions null and void to the extent that they concern the applicants;










—


in the alternative declare null and void the entire UWWTD; and,










—


order the defendants to pay the costs of the proceedings.





Pleas in law and main arguments

In support of the action, the applicants rely on the same pleas in law as in Case T-156/25, Accord Healthcare France v Parliament and Council.


(1)  OJ 2024 L 3019.


ELI: http://data.europa.eu/eli/C/2025/2683/oj
ISSN 1977-091X (electronic edition)
Case T-160/25: Action brought on 7 March 2025 – Fresenius Kabi Deutschland and Others v Parliament and Council
Date: 2025-03-07
Institutions: General Court
Subjects: equal treatment, extended producer responsibility, freedom of association, pharmaceutical industry, polluter pays principle, principle of legal certainty, principle of proportionality, producer's liability, wastewater, water treatment








C_202502676EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2025/2676


19.5.2025






Action brought on 7 March 2025 – Fresenius Kabi Deutschland and Others v Parliament and Council


(Case T-160/25)

(C/2025/2676)
Language of the case: English

Parties


Applicants: Fresenius Kabi Deutschland GmbH (Bad Homburg vor der Höhe, Germany), Fresenius Kabi Italia Srl (FKI) (Verona, Italy), Fresenius Kabi Polska sp. z o.o. (Warszawa, Poland) (represented by: T. Voland, U. Reese, M. Petite, P. Leven, L.-I. Dietz, M. Steininger and K. Schroeder-Finckh, lawyers)

Defendants: European Parliament, Council of the European Union

Form of order sought

The applicants claim that the Court should:






—


declare null and void Article 1, Article 2(19), (20) and (26), Article 9, Article 10, Article 30(1) sub-paragraph 2(c) and (g) and Annex III of the Directive (EU) 2024/3019 of the European Parliament and of the Council of 27 November 2024 concerning urban wastewater treatment (‘UWWTD’) (1);










—


in the alternative declare these provisions null and void to the extent that they concern the applicants;










—


in the alternative declare null and void the entire UWWTD; and,










—


order the defendants to pay the costs of the proceedings.





Pleas in law and main arguments

In support of the action, the applicants rely on the same pleas in law as in Case T-156/25, Accord Healthcare France v Parliament and Council.


(1)  OJ 2024 L 3019.


ELI: http://data.europa.eu/eli/C/2025/2676/oj
ISSN 1977-091X (electronic edition)
Case T-164/25: Action brought on 7 March 2025 – Zakłady Farmaceutyczne Polpharma v Parliament and Council
Date: 2025-03-07
Institutions: General Court
Subjects: equal treatment, extended producer responsibility, freedom of association, pharmaceutical industry, polluter pays principle, principle of legal certainty, principle of proportionality, producer's liability, wastewater, water treatment








C_202502680EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2025/2680


19.5.2025






Action brought on 7 March 2025 – Zakłady Farmaceutyczne Polpharma v Parliament and Council


(Case T-164/25)

(C/2025/2680)
Language of the case: English

Parties


Applicant: Zakłady Farmaceutyczne Polpharma S.A. (Starogard Gdański, Poland) (represented by: T. Voland, U. Reese, M. Petite, P. Leven, L.-I. Dietz, M. Steininger and K. Schroeder-Finckh, lawyers)

Defendants: European Parliament, Council of the European Union

Form of order sought

The applicant claims that the Court should:






—


declare null and void Article 1, Article 2(19), (20) and (26), Article 9, Article 10, Article 30(1) sub-paragraph 2(c) and (g) and Annex III of the Directive (EU) 2024/3019 of the European Parliament and of the Council of 27November 2024 concerning urban wastewater treatment (‘UWWTD’) (1);










—


in the alternative declare these provisions null and void to the extent that they concern the applicant;










—


in the alternative declare null and void the entire UWWTD; and,










—


order the defendants to pay the costs of the proceedings.





Pleas in law and main arguments

In support of the action, the applicant relies on the same pleas in law as in Case T-156/25, Accord Healthcare France v Parliament and Council.


(1)  OJ 2024 L 3019.


ELI: http://data.europa.eu/eli/C/2025/2680/oj
ISSN 1977-091X (electronic edition)
Case T-163/25: Action brought on 7 March 2025 – Exeltis Healthcare and Medical Valley Invest v Parliament and Council
Date: 2025-03-07
Institutions: General Court
Subjects: equal treatment, extended producer responsibility, freedom of association, pharmaceutical industry, polluter pays principle, principle of legal certainty, principle of proportionality, producer's liability, wastewater, water treatment








C_202502679EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2025/2679


19.5.2025






Action brought on 7 March 2025 – Exeltis Healthcare and Medical Valley Invest v Parliament and Council


(Case T-163/25)

(C/2025/2679)
Language of the case: English

Parties


Applicants: Exeltis Healthcare, SL (Azuqueca de Henares, Spain), Medical Valley Invest AB (Höllviken, Sweden) (represented by: T. Voland, U. Reese, M. Petite, P. Leven, L.-I. Dietz, M. Steininger and K. Schroeder-Finckh, lawyers)

Defendants: European Parliament, Council of the European Union

Form of order sought

The applicants claim that the Court should:






—


declare null and void Article 1, Article 2(19), (20) and (26), Article 9, Article 10, Article 30(1) sub-paragraph 2(c) and (g) and Annex III of the Directive (EU) 2024/3019 of the European Parliament and of the Council of 27 November 2024 concerning urban wastewater treatment (‘UWWTD’) (1);










—


in the alternative declare these provisions null and void to the extent that they concern the applicants










—


in the alternative declare null and void the entire UWWTD; and,










—


order the defendants to pay the costs of the proceedings.





Pleas in law and main arguments

In support of the action, the applicants rely on the same pleas in law as in Case T-156/25, Accord Healthcare France v Parliament and Council.


(1)  OJ 2024 L 3019.


ELI: http://data.europa.eu/eli/C/2025/2679/oj
ISSN 1977-091X (electronic edition)
Non-opposition to a notified concentration (Case M.11905 – PSPIB / DIGITALBRIDGE / SKYLINE)
Date: 2025-03-07
Institutions: Directorate-General for Competition, European Commission
Subjects: computer centre, digital infrastructure supply, economic concentration, investment company, merger control, pension scheme








C_202501709EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2025/1709


17.3.2025






Non-opposition to a notified concentration
(Case M.11905 – PSPIB / DIGITALBRIDGE / SKYLINE)
(Text with EEA relevance)
(C/2025/1709)

On 7 March 2025, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:






—


in the merger section of the ‘Competition policy’ website of the Commission (https://competition-cases.ec.europa.eu/search). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,










—


in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32025M11905. EUR-Lex is the online point of access to European Union law.






(1)  
            OJ L 24, 29.1.2004, p. 1.


ELI: http://data.europa.eu/eli/C/2025/1709/oj
ISSN 1977-091X (electronic edition)
Authorisation for State aid pursuant to Articles 107 and 108 of the Treaty on the Functioning of the European Union – Cases where the Commission raises no objections – SA.115978
Date: 2025-03-07
Institutions: Directorate-General for Competition, European Commission
Subjects: Croatia, State aid, carriage of goods, control of State aid, rail transport








C_202501565EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2025/1565


7.3.2025






Authorisation for State aid pursuant to Articles 107 and 108 of the Treaty on the Functioning of the European Union
Cases where the Commission raises no objections
SA.115978
(Text with EEA relevance)
(C/2025/1565)








Date of adoption of the decision


22.1.2025




Aid number


SA.115978




Member State


Croatia




Region


 




Title (title and/or name of the beneficiary)


RRF – Aid scheme to support noise reduction measures for rail freight wagons




Legal basis


Decision of the Ministry of the Sea, Transport and Infrastructure of Croatia, in application of the ‘Operational arrangements between the European Commission and Croatia’, which derives from the ‘Recovery and Resilience Plan’ for Croatia




Type of measure


Scheme


 




Objective


Coordination of transport




Form of aid


Direct grant




Budget


Overall budget: 2 700 000  EUR
Annual budget: 2 000 000  EUR




Intensity


50,0 %




Duration


Until 31.12.2026




Economic sectors


Freight rail transport




Name and address of the granting authority







Ministry of the Sea, Transport and Infrastructure of Croatia




Prisavlje 14, Zagreb








Other information


 




The authentic text(s) of the decision, from which all confidential information has been removed, can be found at:

https://competition-cases.ec.europa.eu/search?caseInstrument=SA



ELI: http://data.europa.eu/eli/C/2025/1565/oj
ISSN 1977-091X (electronic edition)